[go: up one dir, main page]

PE20050582A1 - Derivados de quinolona como agentes antibacterianos - Google Patents

Derivados de quinolona como agentes antibacterianos

Info

Publication number
PE20050582A1
PE20050582A1 PE2004001119A PE2004001119A PE20050582A1 PE 20050582 A1 PE20050582 A1 PE 20050582A1 PE 2004001119 A PE2004001119 A PE 2004001119A PE 2004001119 A PE2004001119 A PE 2004001119A PE 20050582 A1 PE20050582 A1 PE 20050582A1
Authority
PE
Peru
Prior art keywords
cyane
pyrrolidin
cyclopropyl
dihydro
oxo
Prior art date
Application number
PE2004001119A
Other languages
English (en)
Inventor
Edmund Lee Ellsworth
Denton Wade Hoyer
Kim Marie Hutchings
Clarke Bentley Taylor
Sean Timothy Murphy
Mark Ryan Rauckhorst
Jeremy Tyson Starr
Chris Limberakis
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20050582A1 publication Critical patent/PE20050582A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A DERIVADOS DE QUINOLONA DE FORMULA I DONDE X ES N, C CON LA CONDICION DE QUE CUANDO X SEA N, R5 ESTE AUSENTE EN ESA POSICION; R1 ES ALQUILO (C1-C6), HALO-ALQUILO (C1-C6), CICLOALQUILO (C1-C6), HALO-CICLOALQUILO (C3-C6), HETEROCICLILO, ARILO, HETEROARILO, ENTRE OTROS; R2 ES OH, OBF2, O-ALQUILO (C1-C6), O-CICLOALQUILO (C3-C6), ENTRE OTROS; R3, R4 Y R5 SON H, OH, HALO, NRyRz DONDE CADA UNO DE Ry Y Rz ES INDEPENDIENTEMENTE H O ALQUILO (C1-C6); R1 Y R5 TOMADOS JUNTO CON LOS CARBONOS A LOS QUE ESTAN UNIDOS FORMAN UN ANILLO DE 5 O 6 MIEMBROS SUSTITUIDO O NO SUSTITUIDO QUE CONTIENEN 0 A 2 HETEROATOMOS SELECCIONADOS ENTRE O, S, SO, SO2, NRx DONDE Rx ES H, ALQUILO (C1-C6). SON COMPUESTOS PREFERIDOS:ACIDO 7- [3- (2-CIANO-ETILAMINO)-PIRROLIDIN-1-IL]-1-CICLOPROPIL-6-FLUORO-8-METOXI-4- OXO-1, 4-DIHIDRO-QUINOLIN-3-CARBOXILICO; ACIDO 7- [3- (2-CIANO-ETILAMINO)-PIRROLIDIN-1-IL]-1-CICLOPROPIL-6-FLUORO-8-METIL-4-OXO-1, 4-DIHIDRO-QUINOLIN-3-CARBOXILICO; ACIDO 7- {3-[(2-CIANO-ETIL)-METIL-AMINO]-PIRROLIDIN-1-IL}-1-CICLOPROPIL-6-FLUORO-8- METOXI-4-OXO-1, 4-DIHIDRO-QUINOLIN-3-CARBOXILICO; ACIDO 7-{3-[(2-CIANO-ETIL)-METIL-AMINO]-PIRROLIDIN-L-IL}-1-CICLOPROPIL-6-FLUORO-8- METIL-4-OXO-1,4-DIHIDRO-QUINOLIN-3-CARBOXILICO , ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA UTIL PARA EL TRATAMIENTO DE UNA INFECCION BACTERIANA
PE2004001119A 2003-11-18 2004-11-16 Derivados de quinolona como agentes antibacterianos PE20050582A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52307103P 2003-11-18 2003-11-18
US60549604P 2004-08-31 2004-08-31

Publications (1)

Publication Number Publication Date
PE20050582A1 true PE20050582A1 (es) 2005-08-25

Family

ID=34623167

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001119A PE20050582A1 (es) 2003-11-18 2004-11-16 Derivados de quinolona como agentes antibacterianos

Country Status (6)

Country Link
AR (1) AR046638A1 (es)
NL (1) NL1027545C2 (es)
PE (1) PE20050582A1 (es)
TW (1) TW200524930A (es)
UY (1) UY28622A1 (es)
WO (1) WO2005049602A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1666477E (pt) 2003-09-10 2013-08-28 Kyorin Seiyaku Kk Derivado de 7-(4-substituído-3-ciclopropilaminometil-1- pirrolidinil) quinolonecarboxílico
CA2617557A1 (en) 2005-08-04 2007-02-15 Sirtris Pharmaceuticals, Inc. Benzimidazole derivatives as sirtuin modulators
DE102006005861A1 (de) * 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
CN101622240B (zh) * 2007-01-05 2014-07-23 第一三共株式会社 稠合取代氨基吡咯烷衍生物
EP2097400B1 (en) 2007-01-05 2013-07-03 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
US8222407B2 (en) 2007-05-24 2012-07-17 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
DE102007036068A1 (de) * 2007-08-01 2009-02-05 Wacker Chemie Ag Verfahren zur Herstellung von Alkyl-methoxymethyl-trimethylsilanylmethylaminen
US8338622B2 (en) 2008-05-30 2012-12-25 Takeda Pharmaceutical Company Limited Heterocyclic compound
AU2010211672B2 (en) 2009-02-06 2016-08-04 Nippon Shinyaku Co., Ltd. Aminopyrazine derivative and medicine
AR091858A1 (es) * 2012-07-25 2015-03-04 Sova Pharmaceuticals Inc INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
EP3692991A1 (de) 2015-06-09 2020-08-12 Bayer Pharma Aktiengesellschaft Positiv allosterische modulatoren des muskarinergen m2 rezeptors
WO2018011017A1 (de) 2016-07-11 2018-01-18 Bayer Pharma Aktiengesellschaft 7-substituierte 1-pyridyl-naphthyridin-3-carbonsäureamide und ihre verwendung
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
EP3296298A1 (de) 2016-09-14 2018-03-21 Bayer Pharma Aktiengesellschaft 7-substituierte 1-aryl-naphthyridin-3-carbonsäureamide und ihre verwendung
WO2018060073A1 (en) 2016-09-29 2018-04-05 Bayer Cropscience Aktiengesellschaft Novel 5-substituted imidazole derivatives

Also Published As

Publication number Publication date
NL1027545C2 (nl) 2006-01-17
WO2005049602A1 (en) 2005-06-02
UY28622A1 (es) 2005-06-30
NL1027545A1 (nl) 2005-05-23
AR046638A1 (es) 2005-12-14
TW200524930A (en) 2005-08-01

Similar Documents

Publication Publication Date Title
PE20050582A1 (es) Derivados de quinolona como agentes antibacterianos
AR054560A1 (es) Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
PE20130155A1 (es) Derivados de ariletinilo
AR070343A1 (es) Piridinil amidas, un procedimiento para el tratamiento de la esquizofrenia en un mamifero y una composicion farmaceutica
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
PE20091383A1 (es) DERIVADOS DE IMIDAZO-[1,2-a]PIRIDINA COMO INHIBIDORES DE ALK-5 Y ALK-4
NO20084350L (no) Heterocykliske amider til anvendelse som farmasoytika
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
AR079224A1 (es) Compuestos insecticidas basados en derivados de isoxazolina
MX2009005449A (es) Compuesto heteromonociclico y uso del mismo.
AR060618A1 (es) Compuesto de ciclohexilpirazol-lactama composicion farmaceutica que comprende dicho compuesto su uso para la preparacion de un medicamento e intermediarios para prepararlo
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
CO6270288A2 (es) Composicion fungicida que comprende cantidades significativamente efectivas de un derivadio de amida de acido carboxilico o su sal
MX2014015501A (es) Carboxamidas heterociclicas fungicidas.
AR078168A1 (es) Derivados de piperidinas y piperazinas, procesos para prepararlos y sus usos como moduladores de gpr119
EA201390022A1 (ru) Конденсированные гетероциклические соединения в качестве ингибиторов фосфодиэстераз (фдэ)
AR077818A1 (es) Composiciones pesticidas
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
AR061369A1 (es) Derivados de pirimidina y composiciones farmaceuticas que los comprenden
CY1114476T1 (el) Παραγωγο 7-(4-υποκατεστημενου 3-κυκλοπροπυλαμινομεθυλο-1-πυρρολιδινυλο) κινολονοκαρβοξυλικου οξεος
PE20110845A1 (es) Nuevos compuestos heterociclicos nitrogenados, preparacion de los mismos y utilizacion de los mismos como medicamentos antibacterianos
MY145746A (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
AR055563A1 (es) Compuestos de piridil acido acetico, agente farmaceutico y utilizacion del compuesto para preparar dicho agente
CY1115643T1 (el) Διεγερτης νευρογενεσης ή θεραπευτικος παραγων νευροπαθειας που περιλαμβανει παραγωγα αλκυλ αιθερα ή αλας αυτου

Legal Events

Date Code Title Description
FA Abandonment or withdrawal